loader
Please Wait
Applying Filters...
menu
    • menu

    Looking for Pradaxa? Find Controlled & Modified Release used in Pradaxa to address drug delivery challenges on PharmaCompass.

    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients & provides custom-made solutions.

    Virtual Booth

    Contact Supplier

    View Presentation

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-Default-Wallpaper

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-Default-Wallpaper

    Virtual Booth

    Contact Supplier

    Menu

    Pradaxa

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 791Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 2Gangwal Healthcare

    02 2Aeon Procare

    03 3Finar

    04 1Ideal Cures Pvt Ltd

    05 14Kerry

    06 1Kima Chemical

    07 1Lonza Capsugel

    08 2Pluviaendo

    09 2The Dow Chemical Company

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    PharmaCompass

    01

    Gangwal Healthcare

    India
    arrow
    CPhI India 2024
    Booth #8.Q10
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothGangwal Healthcare is powered by innovation, driving health, wellness & healing.

    Dosage Form : Capsule, Tablet

    Grade : Oral

    Brand Name : DiCOM-DC® SR300

    Application : Co-Processed Excipients, Controlled & Modified Release, Direct Compression

    Excipient Details : DiCOM-DC SR300 is used as a directly compressible, rate-controlling, and co-processed excipient in sustained-release tablets and capsules.

    Pharmacopoeia Ref : In-house

    Technical Specs : NA

    Ingredient(s) : EthylCellulose, Hydroxypropyl Cellulose, Hydroxypropyl Methylcellulose, Magnesium Stearate, Maize Starch, Microcrystalline Cellulose, Silicon Dioxide, Talc

    Dosage Form : Capsule, Tablet

    Grade : Oral

    arrow
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothGangwal Healthcare is powered by innovation, driving health, wellness & healing.

    Ingredient(s) : EthylCellulose, Hydroxypropyl Cellulose, Hydroxypropyl Methylcellulose, Magnesium Stearate, Maize Starch, Microcrystalline Cellulose, Silicon Dioxide, Talc

    Dosage Form : Capsule, Tablet

    Category : Co-Processed Excipients, Controlled & Modified Release, Direct Compression

    Brand : DICOM-DC® SR300

    Applications : DiCOM-DC SR300 is used as a directly compressible, rate-controlling, and co-processed excipient in sustained-release tablets and capsules.

    Pharmacopoeia Ref : In-house

    Technical Specs : NA

    Grade : Oral

    arrow
    Gangwal Healthcare DiCOM-DC® SR300

    Excipients Web Link

    Market Place

    Digital Content

    Virtual Booth

    02

    Pluviaendo

    POTASSIUM CHLORIDE

    arrow
    2024 ACI Convention
    Not Confirmed

    03

    Kerry

    SHEFFCEL

    arrow
    2024 ACI Convention
    Not Confirmed

    04

    Aeon Procare

    TALC

    arrow
    2024 ACI Convention
    Not Confirmed

    05

    Kerry

    SHEFFCEL CR

    arrow
    2024 ACI Convention
    Not Confirmed

    06

    Ideal Cures Pvt Ltd

    INSTAMODEL BLEND

    arrow
    2024 ACI Convention
    Not Confirmed

    07

    Kerry

    SHEFFCOAT™ S

    arrow
    2024 ACI Convention
    Not Confirmed

    08

    The Dow Chemical Company

    METHOCEL™

    arrow
    2024 ACI Convention
    Not Confirmed

    The Dow Chemical Company

    U.S.A
    arrow
    2024 ACI Convention
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Dosage Form : Tablet, Capsule

    Grade :

    Brand Name : METHOCEL™

    Application : API Stability Enhancers, Coating Systems & Additives, Controlled & Modified Release, Direct Compression, Granulation, Rheology Modifiers, Vegetarian Capsules

    Excipient Details : Controlled Release, Direct Compression,Wet Granulation,Tablet Coating, Liquid Solutions and Suspensions

    Pharmacopoeia Ref :

    Technical Specs :

    Ingredient(s) : Hydroxypropyl Methylcellulose

    Dosage Form : Tablet, Capsule

    Grade :

    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Ingredient(s) : Hydroxypropyl Methylcellulose

    Dosage Form : Tablet, Capsule

    Category : API Stability Enhancers, Coating Systems & Additives, Controlled & Modified Release, Direct Compression, Granulation, Rheology Modifiers, Vegetarian Capsules

    Brand : METHOCEL™

    Applications : Controlled Release, Direct Compression,Wet Granulation,Tablet Coating, Liquid Solutions and Suspensions

    Pharmacopoeia Ref : Not Available

    Technical Specs : Not Available

    Grade : Not Available

    arrow
    blank

    Excipients Web Link

    Market Place

    Digital Content

    Virtual Booth

    09

    Kerry

    SHEFFCOAT™ENHANCE

    arrow
    2024 ACI Convention
    Not Confirmed

    10

    Kima Chemical

    HYDROXYPROPYL METHYL CELLULOSE (75K100)

    arrow
    2024 ACI Convention
    Not Confirmed

    11

    Kerry

    SHEFFCOAT™ GLIDE

    arrow
    2024 ACI Convention
    Not Confirmed

    12

    Kerry

    SHEFFCOAT™ L

    arrow
    2024 ACI Convention
    Not Confirmed

    13

    Finar

    POTASSIUM CHLORIDE

    arrow
    2024 ACI Convention
    Not Confirmed

    14

    Kerry

    SHEFFCOAT™

    arrow
    2024 ACI Convention
    Not Confirmed

    15

    Lonza Capsugel

    VCAPS® ENTERIC

    arrow
    2024 ACI Convention
    Not Confirmed

    Lonza Capsugel

    U.S.A
    arrow
    2024 ACI Convention
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Dosage Form : Capsule

    Grade : Oral

    Brand Name : Vcaps® Enteric

    Application : Controlled & Modified Release, Vegetarian Capsules

    Excipient Details : It offers an enteric-release profile to the upper gastro-intestinal tract that meets the disintegration requirements for delayed-release capsules for the European, US and Japanese Phamacopoeia.

    Pharmacopoeia Ref : Complies with relevant Europea...

    Technical Specs : Water content – less than 6%; Size #0

    Ingredient(s) : HPMC AS, Hydroxypropyl Methyl Cellulose

    Dosage Form : Capsule

    Grade : Oral

    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Ingredient(s) : HPMC AS, Hydroxypropyl Methyl Cellulose

    Dosage Form : Capsule

    Category : Controlled & Modified Release, Vegetarian Capsules

    Brand : VCAPS® ENTERIC

    Applications : It offers an enteric-release profile to the upper gastro-intestinal tract that meets the disintegration requirements for delayed-release capsules for the European, US and Japanese Phamacopoeia.

    Pharmacopoeia Ref : Complies with relevant European, Japanese and US Pharmacopeia monographs

    Technical Specs : Water content – less than 6%; Size #0

    Grade : Oral

    arrow
    blank

    Excipients Web Link

    Market Place

    Digital Content

    Virtual Booth

    16

    Kerry

    SHEFFCOAT™ CG

    arrow
    2024 ACI Convention
    Not Confirmed

    17

    Kerry

    SHEFFCOAT™ D

    arrow
    2024 ACI Convention
    Not Confirmed

    18

    Kerry

    SHEFFCOAT™ EC

    arrow
    2024 ACI Convention
    Not Confirmed

    19

    Kerry

    SHEFFCOAT™ HS

    arrow
    2024 ACI Convention
    Not Confirmed

    20

    Kerry

    SHEFFCOAT™ MP

    arrow
    2024 ACI Convention
    Not Confirmed